Comment from Karen Eileen McKeen
AnonymousOpposeIndividual
Summary: A patient with multiple sclerosis argues that the proposed action would be devastating because it could make IV ALA unavailable. They claim that IV ALA has significantly improved their quality of life and ability to work, and they believe the FDA should not prevent its use.
I have been receiving IV ALA since 2013 to help deal with my multiple sclerosis. Up to this point my physicians have prescribed
a number of medications and procedures to slow the progression of my disease. Some have helped others have not but I
can say without a doubt that since starting on the IV ALA and B my life has improved exponentially. This action would be
devastating to me should the IV ALA become unavailable. Prior to starting the treatment I was dealing with chronic fatigue,
memory loss and the inability to focus at work to name a few. Because of the IV ALA I have able to maintain my work as a
CFO (medium size health care organization, $50M annually) and have an independent home life. I definitely do not want to go
backwards! In addition, the number of people seeking this health benefit from the USA and around the world is astonishing.
In my opinion it would be criminal for the FDA to prevent the use of IV ALA.